IRADIMED CORP (IRMD)

US46266A1097 - Common Stock

41.86  +0.39 (+0.94%)

After market: 41.86 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
41.81M
31.81%		53.3M
27.48%		65.562M
23.01%		74.266M
13.28%
EBITDA
YoY % growth
11.23M
1,836.21%		16.3M
45.15%		20.801M
27.61%		22.593M
8.62%		N/A
EBIT
YoY % growth
9.82M
1,392.11%		15.63M
59.16%		20.035M
28.19%		21.068M
5.15%
Operating Margin
23.49%29.32%30.56%28.37%
EPS
YoY % growth
0.83
102.44%		1.09
31.33%		1.48
35.78%		1.56
5.45%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		0.34
13.90%
Revenue
Q2Q % growth		17.508M
13.10%
EBITDA
Q2Q % growth		4.937M
EBIT
Q2Q % growth		4.554M
13.57%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.39
21.88%		0.40-0.01-3.61%
Q3 2023
Q2Q % growth		 0.43
48.28%		0.370.0616.03%
Q2 2023
Q2Q % growth		 0.36
38.46%		0.320.0413.85%
Q1 2023
Q2Q % growth		 0.30
36.36%		0.290.013.81%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 17.452M
17.44%		17.678M-225.82K-1.28%
Q3 2023
Q2Q % growth		 16.5M
23.04%		16.499M1K0.01%
Q2 2023
Q2Q % growth		 16.13M
26.81%		15.963M167K1.05%
Q1 2023
Q2Q % growth		 15.48M
25.75%		15.062M418K2.78%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-6.94% -18.29% -3.77% -8.57%
Revenue-1.35% -2.51% -0.43% 0.29%